Obenshain Andrew's Form 4 filing
bluebird bio, Inc. (BLUE) · filed Oct 2, 2024
- Accession no.
- 0001562180-24-007124
- Filed
- Oct 2, 2024
- Trade date
- Sep 30, 2024
- Filing delay
- 2 days
- Rule 10b5-1 plan
- Checked
This filing lists 2 non-derivative transactions. Open-market sales total $18.4K. It was filed 2 days after the trade.
Reporting owners
A Form 4 can have several reporting owners, such as a person and a fund they control. Trade tables show the first one.
| Owner | Relationship to the company |
|---|---|
| Obenshain AndrewCIK 0001839697 | Director, Officer (President and CEO) |
Non-derivative securities (Table I)
Acquisitions and disposals of common stock and similar shares, one row per line on the filing.
| Trade date | Security | Transaction | Shares | Price | Value | Shares after | Ownership | Flags |
|---|---|---|---|---|---|---|---|---|
| Sep 30, 2024 | Common Stock | AGrant or awardAcquired | +130,000 | $0.00 | $0 | 409,998 | Direct | |
| Sep 30, 2024 | Common Stock | SSaleDisposed | −34,780 | $0.53F3 | −$18,433.4 | 375,218 | Direct |
Footnotes and remarks
Livermore keeps the footnotes that transaction prices refer to, all footnotes of amendments (Form 4/A) and the filing's remarks. Other footnotes, such as how indirect holdings are held or the details of a trading plan, are only in the original on SEC EDGAR.
- F3
The range in prices for the transaction reported on this line was $0.5211 to $0.5273. The average weighted price was $0.5253. The reporting person will provide, upon request by the SEC, the issuer or security holder of the issuer, full information regarding the number of shares sold at each separate price.
Referenced by the price of 1 transaction in Table I.